Sanofi(SNY) - 2022 Q4 - Annual Report

Exhibit 99.2 Press Release Business net income (a non-IFRS financial measure) for the year ended December 31, 2022 is unchanged, as is the amount of the dividend proposed by the Board of Directors held on February 2, 2023. Updated IFRS figures for 2022 Financial Statements1 | | Q4 2022 | Change | Change | 2022 | Change | Change | | --- | --- | --- | --- | --- | --- | --- | | | | | at CER | | | at CER | | IFRS net sales reported | €10,725m | +7.3% | +2.6% | €42,997m | +13.9% | +7.0% | | IFRS net income repor ...